<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Dipeptides and Tripeptides: The Emerging Frontier of Collagen Science</title>
  <description> Standard collagen supplements get broken down to individual amino acids during digestion, but specific di- and tripeptides resist digestive enzymes, enter your bloodstream intact, and may act as signaling molecules that stimulate collagen production, fibroblast activity, and hyaluronic acid synthesis German company Gelita produces target-specific bioactive collagen peptide formulations for joints, skin, and bone, each backed by randomized, placebo-controlled clinical trials The Japanese company Nitta Gelatin first identified these key bioactive dipeptides from within the collagen peptide molecule over a decade ago, and their Replenwell line contains up to 30 times more bioactive dipeptides than standard collagen A 2024 five-arm multicenter randomized controlled trial showed that 2.5 grams of concentrated bioactive collagen peptides matched the efficacy of 10 grams of conventional collagen — a four-fold potency advantage Gelita’s consumer-available hydrolysate powder — roughly $40 for a pound — is currently a practical option, though a commonly studied intake is about 10 grams per day  </description>
  <author_name>Dr. Joseph Mercola - Take Control of Your Health</author_name>
  <author_url>http://www.mercola.com/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41269025/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/201873855</thumbnail_url>
</oembed>
